JAZZ vs NXPI · P/E 1988, rev $2.28B vs P/E 29, rev $12.27B
Jazz Pharmaceuticals PLC (JAZZ) versus NXP Semiconductors NV (NXPI) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Not investment advice. Open the JAZZ and NXPI stock pages for the full models.
Not investment advice.